Hospital Corporation of China Limited, an investment holding company, owns, operates, and manages hospitals in the People's Republic of China. It operates through three segments: General Hospital Services; Hospital Management Services; and Sale of Pharmaceutical Products. The company offers inpatient and outpatient, operation management, management, supply chain, and other ancillary services to certain hospitals; and property management services. It also engages in the wholesale and retail of pharmaceutical products and medical devices. The company was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China. Hospital Corporation of China Limited operates as a subsidiary of Vanguard Glory Limited.
Frequently asked questions
What sector does Hospital Corporation of China Ltd (3869) operate in?
Hospital Corporation of China Ltd belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Hospital Corporation of China Ltd (3869) current stock price?
As of the latest data, Hospital Corporation of China Ltd stock price is HK$3.40, with a previous close of HK$3.40.
What is Hospital Corporation of China Ltd (3869) current market capitalization?
Hospital Corporation of China Ltd market cap is approximately 464.09 million.
What is Hospital Corporation of China Ltd (3869) EBITDA?
Hospital Corporation of China Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 118.73 million.
Does Hospital Corporation of China Ltd (3869) pay dividends?
No. Hospital Corporation of China Ltd does not pay a dividend.
What is Hospital Corporation of China Ltd (3869) beta (volatility) score?
Hospital Corporation of China Ltd has a beta of -0.309, indicating lower volatility than the overall market.
